Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop

Andrew J Thompson1, Claire L Padgett, Sarah C R Lummis

  • 1Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, UK.

Insights

The 5-HT(3) receptor

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • The 5-HT(3) receptor is a Cys-loop ligand-gated ion channel crucial for neurotransmission.
  • Its extracellular domain features six loops (A-F) forming the ligand-binding site.
  • The F-loop's role in ligand interaction is not fully understood.

Purpose of the Study:

  • To investigate the role of specific residues within the 5-HT(3) receptor F-loop in ligand binding.
  • To identify regions within the F-loop critical for binding affinity and selectivity.

Main Methods:

  • Site-directed mutagenesis of 21 residues in the 5-HT(3) receptor F-loop.
  • Expression of mutant receptors in HEK293 cells.
  • Measurement of binding affinity using [(3)H]granisetron and homology modeling.

Main Results:

  • Mutations to Ala revealed two regions (Ile(192)-Arg(196) and Asp(204)-Ser(206)) critical for binding affinity.
  • Mutations to chemically similar residues highlighted a sensitive region (Ile(192)-Val(201)).
  • Homology modeling suggested distinct movements of Trp(195) and Asp(204) upon ligand binding, indicating differential flexibility.

Conclusions:

  • The 5-HT(3) receptor F-loop is flexible and plays a specific role in ligand binding.
  • Distinct regions within the F-loop contribute uniquely to ligand interaction and affinity.
  • Residues like Trp(195) and Asp(204) exhibit differential mobility, influencing ligand binding specificity.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...